Comparison

Exisulind European Partner

Item no. TMO-T24051-10mg
Manufacturer TargetMol
CASRN 59973-80-7
Amount 10mg
Category
Type Inhibitor
Specific against other
Purity 0,98
Smiles O=C(O)CC=1C=2C=C(F)C=CC2C(=CC3=CC=C(C=C3)S(=O)(=O)C)C1C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Apoptosis, PKA, Sulindac sulfone , CP248
Available
Short Description
Exisulind induces apoptosis through the activation of protein kinase G (PKG). Exisulind exhibits antineoplastic activity in solid tumour and haematological cancer cell lines and is an inhibitor of tumour growth in rodent models of colon, prostate, bladder, mammary and lung cancer.
Shipping
cool pack
Storage
-20°
Target names or alias
Sulindac sulfone , CP248
Molecular Weight
372, 41
Pathway
Apoptosis|||Tyrosine Kinase/Adaptors
Target
Apoptosis|||PKA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close